ArticleClinical medicine insights. Case reports2026
Adult-Onset Still's Disease Presenting With Persistent Hyperpigmented Scaling Rash in a Young Ethiopian Woman: A Case Report From a Resource-Limited Setting.
Article in Clinical medicine insights. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Adult-onset Still's disease (AOSD) is a rare systemic autoinflammatory disorder characterized by high-spiking fever, arthritis, rash, and systemic inflammation. Because there is no single diagnostic test, diagnosis relies on compatible clinical features, fulfillment of classification criteria, and exclusion of infectious, malignant, and autoimmune conditions. Atypical cutaneous manifestations may further delay recognition, particularly in resource-limited settings. Case Presentation: We report the case of a 22-year-old Ethiopian woman who presented with a five-month history of inflammatory polyarthritis, daily spiking fever, sore throat, and a persistent hyperpigmented scaling rash rather than the classic evanescent salmon-colored eruption. Laboratory evaluation demonstrated marked neutrophilic leukocytosis, elevated inflammatory markers, abnormal liver enzymes, and hyperferritinemia (1,675 μg/L). Echocardiography revealed mitral valvulitis with mild pericardial effusion. Infectious, autoimmune, and rheumatologic conditions, including acute rheumatic fever, rheumatoid arthritis, systemic lupus erythematosus, viral hepatitis, HIV infection, and other competing diagnoses, were excluded through clinical assessment and laboratory investigations. The patient fulfilled the Yamaguchi classification criteria for AOSD, while markedly elevated serum ferritin provided supportive evidence for the diagnosis. She was treated with intravenous pulse methylprednisolone followed by oral prednisolone and methotrexate, resulting in rapid resolution of fever, marked improvement in joint symptoms, fading of the skin lesions, and complete resolution of the pericardial effusion at one-month follow-up. Conclusion: This case highlights the diagnostic challenges of AOSD when atypical dermatologic manifestations occur, particularly in resource-limited settings where infectious diseases are frequently prioritized in the differential diagnosis. Persistent hyperpigmented scaling lesions should not exclude consideration of AOSD when accompanied by characteristic systemic features. Although elevated serum ferritin is not diagnostic, it can provide valuable supportive evidence when interpreted alongside clinical findings and after exclusion of alternative diagnoses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.